Alx Oncology Holdings (ALXO) Total Debt (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Total Debt data on file, last reported at $8.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt fell 14.63% year-over-year to $8.5 million; the trailing twelve-month figure through Mar 2026 stood at $8.5 million (down 14.63% YoY), and the FY2025 full-year result was $9.7 million, down 1.57% from the prior year.
• Total Debt retreated to $8.5 million in Q1 2026, from $9.7 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $11.0 million in Q4 2022 to a low of $2.5 million in Q2 2022.
• A 5-year average of $8.9 million and a median of $9.8 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt soared 577.24% in 2022 and retreated 14.63% in 2026, its largest moves.
• Tracing ALXO's Total Debt over 5 years: stood at $11.0 million in 2022, then decreased by 12.68% to $9.6 million in 2023, then gained by 2.75% to $9.9 million in 2024, then dropped by 1.57% to $9.7 million in 2025, then slipped by 12.69% to $8.5 million in 2026.
• Business Quant data shows ALXO's Total Debt at $8.5 million in Q1 2026, $9.7 million in Q4 2025, and $10.1 million in Q3 2025.